Silexion Therapeutics Ltd... (SLXN)
NASDAQ: SLXN
· Real-Time Price · USD
7.39
0.03 (0.41%)
At close: Aug 15, 2025, 3:56 PM
7.24
-2.03%
After-hours: Aug 15, 2025, 07:47 PM EDT
Silexion Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Mar 31, 2021 |
Net Income | -16.83M | -16.52M | -16.45M | -5.4M | -3.75M | -2.33M | -152.41K | 949.16K | 828.91K | 584.02K | -152.15K | -542.49K | -585.18K | -339.52K | -97.75K |
Depreciation & Amortization | 21K | 25K | 43K | 31K | 24K | 16.02K | 10.02K | 15.00 | 15.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 5.88M | 5.86M | 5.86M | 98.03K | 66.03K | 66.03K | 32.03K | 32.00 | 32.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -2.38M | -2.19M | -692K | 99.84K | -339.66K | 90.34K | -176.17K | 50.52K | 162.82K | 363.11K | 265.37K | -519.36K | -455.16K | -655.45K | -713.21K |
Other Non-Cash Items | 3.73M | 3.82M | 4.02M | 286.12K | 202.71K | 34.55K | 91.95K | 234.00 | -35.7K | -130.7K | -330.54K | -315.21K | -278.86K | -183.67K | 5.78K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.9M | -1.58M | -203K | 226.84K | -251.66K | 253.34K | -21.17K | 50.52K | 162.82K | 363.11K | 265.37K | -519.36K | -455.16K | -655.45K | -713.21K |
Operating Cash Flow | -9.1M | -8.4M | -6.73M | -4.76M | -3.71M | -1.96M | -39.59K | 999.97K | 956.08K | 816.44K | -217.32K | -1.38M | -1.32M | -1.18M | -805.18K |
Capital Expenditures | -22K | -22K | -26K | -16K | -16K | -10K | -6K | n/a | -4 | -4 | -4 | 2.00 | 6.00 | 6.00 | 3.00 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 78K | 78K | 78.51K | 78.51K | 507.00 | 507.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -22K | -22K | -26K | 62K | 62K | 68.51K | 72.51K | 507.00 | 507.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | 535K | 535K | 725K | 1.07M | 600K | 890K | 1M | 500.01K | 440.01K | 150.01K | -149.99K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.48M | 2.05M | 2.3M | n/a | n/a | -90.37M | -90.37M | -90.37M | -90.37M | n/a | n/a | -2.55M | -2.55M | -2.55M | -2.55M |
Financial Cash Flow | 12.54M | 5.1M | 2.92M | n/a | 535K | -89.83M | -89.64M | -89.29M | -89.77M | 890K | 1M | 116.75M | 116.69M | 116.4M | 116.1M |
Net Cash Flow | 3.4M | -3.38M | -3.79M | -4.74M | -3.7M | -1.88M | -850.67K | 12.86K | -111.36K | 20.77K | 87.75K | 198.21K | 359.41K | 219.35K | 294.99K |
Free Cash Flow | -9.12M | -8.42M | -6.75M | -4.78M | -3.72M | -1.97M | -45.58K | 999.97K | 956.08K | 816.43K | -217.33K | -1.38M | -1.32M | -1.18M | -805.18K |